[Lymphokine activated-killer cell (LAK) activity in patients with hepatocellular carcinoma and its modification by a biological response modifier].
D001688:Biological Products / Q000494:pharmacology*; D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D006801:Humans; D007694:Killer Cells, Natural / Q000187:drug effects / Q000276:immunology*; D008113:Liver Neoplasms / Q000276:immunology*; D008222:Lymphokines / Q000276:immunology*; D010844:Picibanil / Q000494:pharmacology*
D001688:Biological Products; D008222:Lymphokines; D010844:Picibanil